The corona vaccine that the United States tested on humans in March has shown surprising results.

.
 Moderina, a US biotech company, says the first phase of testing the corona vaccine on humans has been successful and the vaccine has been administered to all 45 volunteers. I make antibodies.
According to Dawn News, Moderina's Chief Executive Officer (CEO) Stephen Bensel said that after the initial success, his company is now ready for the third phase of the vaccine, which will be launched in July and if successful A formal application for a license to manufacture the vaccine will be made. Moderina is one of seven companies that have tested their vaccine on humans.

Sudden increase in the number of corona virus patients in India, what is the total number? Disturbing statistics continue
He said he was investing heavily in the development of corona vaccines to save corona patients by making the vaccine more efficient. The company's shares were announced after the company announced a successful trial of the vaccine. I saw the stock market rise by 39%.
 According to the company, the mRNA 173 vaccine is generally safe and well tolerated, while the vaccine protects the lungs from antiviral diseases and the amount of antibodies needed to protect mice from the virus. Yes, the same amount is enough for human beings.
The New York Times, on the other hand, commented on the company's announcement, saying that the vaccine had been tested on a limited number of people in the first phase and that its claims of success could create uncertainty.